AstraZeneca PLC
1302.00
17-April-25 05:59:35
15 minutes delayed
Stocks
-28.50
-2.14%
Today's range
1298.00 - 1323.00
ISIN
N/A
Source
NASD.OMX SE
-
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
15 Feb 2025 08:07:29 By NASDAQ US Markets
-
AZN April 4th Options Begin Trading
13 Feb 2025 11:18:24 By NASDAQ US Markets
-
Why AstraZeneca Topped the Market on Thursday
06 Feb 2025 16:24:24 By NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
06 Feb 2025 13:13:48 By NASDAQ US Markets
-
06 Feb 2025 09:38:48 By NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU
03 Feb 2025 01:58:39 By NASDAQ US Markets
-
Interesting AZN Put And Call Options For March 14th
30 Jan 2025 10:09:34 By NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer
27 Jan 2025 19:00:56 By NASDAQ US Markets
-
InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders
22 Jan 2025 12:41:38 By Forbes - World
-
FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer
18 Jan 2025 00:34:04 By NASDAQ US Markets
-
Better Buy: Novo Nordisk vs. AstraZeneca
04 Jan 2025 05:11:10 By NASDAQ US Markets
-
Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts
27 Dec 2024 01:32:04 By NASDAQ US Markets
-
AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan
24 Dec 2024 01:40:25 By NASDAQ US Markets
-
22 Dec 2024 05:16:51 By NASDAQ US Markets
-
3 Unstoppable Stocks to Buy Right Now
15 Dec 2024 05:33:05 By NASDAQ US Markets
-
March 2025 Options Now Available For AstraZeneca (AZN)
06 Dec 2024 10:01:12 By NASDAQ US Markets
-
AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer
05 Dec 2024 21:31:29 By NASDAQ US Markets
-
FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer
04 Dec 2024 20:59:20 By NASDAQ US Markets
-
AstraZeneca Names A MSK Leader To Global Cancer Post
25 Nov 2024 10:17:34 By Forbes - World
-
Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions
18 Nov 2024 12:17:39 By NASDAQ US Markets